Methodological issues in pooled analysis of biomarker studies
Related Experiment Video
Updated: Sep 26, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
Published on: January 28, 2014
Emanuela Taioli1, Stefano Bonassi
1Molecular and Genetic Epidemiology Unit, Ospedale Maggiore IRCCS, University of Milan, Via F. Sforza, 28, Italy. sget@iol.it
Abstract:
The number of epidemiological studies involving biological markers has dramatically increased in the last years. These studies are generally small sized and this feature has called attention to the need to summarize the individual results, while waiting for the completion of larger studies, designed to answer questions that have been raised by preliminary studies. We describe here some of the methodological issues related to pooling data of biomarker studies, taking advantage of the experience accumulated by conducting two pooled analyses, one of studies of metabolic gene polymorphisms and cancer, the other on cytogenetic damage. Topics that are considered are: data standardization, population selection and bias, statistical analysis, ethical issues. Pooled analysis seems to provide a relevant improvement over meta-analysis in molecular epidemiology studies, though more research on methodology is needed.
More Related Videos
07:35Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
Published on: October 11, 2018
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
Related Concept Videos
Analysis of Population Pharmacokinetic Data
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioavailability Study Design: Healthy Subjects Versus Patients
Measurement of Bioavailability: Pharmacodynamic Methods
Bias in Epidemiological Studies